Drug intelligence / Profile preview

oxazepam

Development stage
Approved
Lead developer
Pfizer
Modality
Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Oxazepam is a short-acting benzodiazepine used primarily for the treatment of anxiety disorders and acute alcohol withdrawal symptoms. It also has sedative-hypnotic, anticonvulsant, muscle relaxant, and amnesic properties. Oxazepam acts as a positive allosteric modulator at the GABA-A receptor in the central nervous system, enhancing the inhibitory effect of gamma-aminobutyric acid (GABA) and thereby reducing neuronal excitability. Its pharmacokinetics are characterized by direct glucuronidation in the liver to inactive metabolites, making it suitable for elderly patients or those with impaired hepatic function. Compared to other benzodiazepines like diazepam, oxazepam has a shorter half-life and lower abuse potential due to slower absorption and brain entry[3][4][5][7].

Brand names
Serax舒宁
Other names
奥沙西泮去甲羟安定
02

Targets

BZD site (GABA-A receptor benzodiazepine site)

Beyond the preview

Go deeper on oxazepam.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oxazepam.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call